Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$29.22 0.18 (0.62%) as of 4:30 Thu 3/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.44(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.32 - $47.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 208,796 351,548
Total Sell Value $3,656,226 $3,656,226 $7,121,778 $16,615,472
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 37 64
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 247
  Page 3 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 AS $55.55 $555,500 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-11-18 4 A $0.00 $0 D/D 414 2,987     -
   Patou Gary Chief Medical Officer   •       –      –    2013-11-18 4 A $0.00 $0 I/I 83 198     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 AS $50.60 $2,556,980 D/D (50,000) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 OE $10.81 $540,500 D/D 50,000 50,000     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 AS $48.92 $978,400 D/D (20,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 OE $1.61 $32,200 D/D 20,000 20,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 AS $46.74 $467,400 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-09-30 4 AS $47.01 $705,741 D/D (15,000) 2,573     -
   Stack David M President and CEO   •       •      –    2013-09-30 4 OE $1.61 $24,150 D/D 15,000 17,573     -
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 AS $46.74 $116,850 D/D (2,500) 0     -
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 OE $1.61 $4,025 D/D 2,500 2,500     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-09-25 4 AS $47.00 $470,000 D/D (10,000) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-09-25 4 OE $5.49 $54,900 D/D 10,000 10,000     -
   Kronenfeld Mark A. Director   –       •      –    2013-09-11 4 B $37.01 $37,010 D/D 1,000 1,000 2.39     -
   Wicki Andreas Director   –       •      –    2013-09-11 4 S $37.25 $662,417 I/I (17,783) 1,692,194     -
   Wicki Andreas Director   –       •      –    2013-09-11 4 OE $2.69 $662,390 I/I 79,033 1,707,291     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 AS $37.00 $543,900 D/D (14,700) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 OE $1.61 $23,667 D/D 14,700 14,700     -
   Wicki Andreas Director   –       •      –    2013-07-22 4 AS $35.28 $703,508 I/I (19,938) 1,630,944     -
   Wicki Andreas Director   –       •      –    2013-07-19 4 AS $34.98 $1,959,524 I/I (56,020) 1,650,882     -
   Wicki Andreas Director   –       •      –    2013-07-18 4 AS $34.80 $140,662 I/I (4,042) 1,706,902     -
   Wicki Andreas Director   –       •      –    2013-07-17 4 AS $33.20 $714,398 I/I (21,518) 1,710,944     -

  247 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed